Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...

Acupuncture shows promise in reducing overactive bladder symptoms and stress incontinence ... Warning signs requiring medical attention include frequent urination, pain during urination, or inability ...